88 related articles for article (PubMed ID: 36639658)
1. Targeting RORγ inhibits the growth and metastasis of hepatocellular carcinoma.
Liu Q; Wang J; Sun H; Zhang Z; Wang H; Ma S; Zhang C; Wang Q; Cai G; Zheng J; Nie Y; Liu P; Wang J
Mol Ther; 2024 Mar; 32(3):749-765. PubMed ID: 38310356
[TBL] [Abstract][Full Text] [Related]
2. Targeting Ferroptosis-Elicited Inflammation Suppresses Hepatocellular Carcinoma Metastasis and Enhances Sorafenib Efficacy.
Mu M; Huang CX; Qu C; Li PL; Wu XN; Yao W; Shen C; Huang R; Wan CC; Jian ZW; Zheng L; Wu RQ; Lao XM; Kuang DM
Cancer Res; 2024 Mar; 84(6):841-854. PubMed ID: 38231484
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of protein translation under matrix-deprivation stress in breast cancer cells.
Warrier S; Srinivasan S; Chedere A; Rangarajan A
Front Med (Lausanne); 2023; 10():1124514. PubMed ID: 37425300
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid Receptors Drive Breast Cancer Cell Migration and Metabolic Reprogramming via PDK4.
Dwyer AR; Perez Kerkvliet C; Truong TH; Hagen KM; Krutilina RI; Parke DN; Oakley RH; Liddle C; Cidlowski JA; Seagroves TN; Lange CA
Endocrinology; 2023 Jun; 164(7):. PubMed ID: 37224504
[TBL] [Abstract][Full Text] [Related]
5. A Novel CD206 Targeting Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice.
Ghebremedhin A; Salam AB; Adu-Addai B; Noonan S; Stratton R; Ahmed MSU; Khantwal C; Martin GR; Lin H; Andrews C; Karanam B; Rudloff U; Lopez H; Jaynes J; Yates C
Cells; 2023 Apr; 12(9):. PubMed ID: 37174654
[TBL] [Abstract][Full Text] [Related]
6. Anoikis in phenotypic reprogramming of the prostate tumor microenvironment.
Nepali PR; Kyprianou N
Front Endocrinol (Lausanne); 2023; 14():1160267. PubMed ID: 37091854
[TBL] [Abstract][Full Text] [Related]
7. CEMIP-mediated hyaluronan metabolism facilitates SCLC metastasis by activating TLR2/c-Src/ERK1/2 axis.
Li L; Shen X; Mo X; Chen Z; Yu F; Mo X; Song J; Huang G; Liang K; Luo Z; Mao N; Yang J
Biochim Biophys Acta Mol Cell Res; 2023 Jun; 1870(5):119451. PubMed ID: 36931608
[TBL] [Abstract][Full Text] [Related]
8. CEMIP, acting as a scaffold protein for bridging GRAF1 and MIB1, promotes colorectal cancer metastasis via activating CDC42/MAPK pathway.
Xu G; Zhao L; Hua Q; Wang L; Liu H; Lin Z; Jin M; Wang J; Zhou P; Yang K; Wu G; Yu D; Zhang D; Zhang T
Cell Death Dis; 2023 Feb; 14(2):167. PubMed ID: 36849460
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics based exploration of hsa-miR-194-5p regulation of CHD4 through PI3K/AKT signal pathway to enhance tumor resistance to apoptosis due to loss of nests and participate in poor prognosis of oral squamous cell carcinoma.
Li Q; Wang K; Shen Y; Lin C; Miao J; Hu X
Ann Transl Med; 2023 Jan; 11(2):107. PubMed ID: 36819582
[TBL] [Abstract][Full Text] [Related]
10. CEMIP promotes small cell lung cancer proliferation by activation of glutamine metabolism via FBXW7/c-Myc-dependent axis.
Mo X; Shen X; Mo X; Yu F; Tan W; Deng Z; He J; Luo Z; Chen Z; Yang J
Biochem Pharmacol; 2023 Mar; 209():115446. PubMed ID: 36746261
[TBL] [Abstract][Full Text] [Related]
11. Chitosan oligosaccharide suppresses osteosarcoma malignancy by inhibiting CEMIP via the PI3K/AKT/mTOR pathway.
Sim I; Choe W; Ri J; Su H; Moqbel SAA; Yan W
Med Oncol; 2023 Sep; 40(10):294. PubMed ID: 37668818
[TBL] [Abstract][Full Text] [Related]
12. Research on the biological mechanism and potential application of CEMIP.
Liu Y; Hu G; Li Y; Kong X; Yang K; Li Z; Lao W; Li J; Zhong J; Zhang S; Leng Y; Bi C; Zhai A
Front Immunol; 2023; 14():1222425. PubMed ID: 37662915
[TBL] [Abstract][Full Text] [Related]
13. Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis.
Rodrigues G; Hoshino A; Kenific CM; Matei IR; Steiner L; Freitas D; Kim HS; Oxley PR; Scandariato I; Casanova-Salas I; Dai J; Badwe CR; Gril B; Tešić Mark M; Dill BD; Molina H; Zhang H; Benito-Martin A; Bojmar L; Ararso Y; Offer K; LaPlant Q; Buehring W; Wang H; Jiang X; Lu TM; Liu Y; Sabari JK; Shin SJ; Narula N; Ginter PS; Rajasekhar VK; Healey JH; Meylan E; Costa-Silva B; Wang SE; Rafii S; Altorki NK; Rudin CM; Jones DR; Steeg PS; Peinado H; Ghajar CM; Bromberg J; de Sousa M; Pisapia D; Lyden D
Nat Cell Biol; 2019 Nov; 21(11):1403-1412. PubMed ID: 31685984
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
[TBL] [Abstract][Full Text] [Related]
15. DJ-1/FGFR-1 Signaling Pathway Contributes to Sorafenib Resistance in Hepatocellular Carcinoma.
Chen X; Yang G; Guo X; Zhang J; Sun W; Liu D; Wang H; Liu S
Oxid Med Cell Longev; 2022; 2022():2543220. PubMed ID: 35770048
[TBL] [Abstract][Full Text] [Related]
16. The role of CEMIP in tumors: An update based on cellular and molecular insights.
Chen Y; Zhou H; Jiang WJ; Wang JF; Tian Y; Jiang Y; Xia BR
Biomed Pharmacother; 2022 Feb; 146():112504. PubMed ID: 34922110
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of lncRNA NIFK-AS1 in hepatocellular carcinoma by m
Chen YT; Xiang D; Zhao XY; Chu XY
Hum Cell; 2021 Nov; 34(6):1800-1811. PubMed ID: 34374933
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of CEMIP potentiates the effect of sorafenib on metastatic hepatocellular carcinoma by reducing the stiffness of lung metastases.
Liu M; Xie L; Zhang Y; Chen J; Zhang X; Chen Y; Huang W; Cai M; Liang L; Lai M; Huang J; Guo Y; Lin L; Zhu K
Cell Death Dis; 2023 Jan; 14(1):25. PubMed ID: 36639658
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
